Back
Day Range
$51.60
$56.95
52-Week Range
$49.00
$65.44
Volume
2
50D / 200D Avg
$62.38
/
$64.68
Prev Close
$56.95
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 27.9 | 0.4 |
| P/B | 6.2 | 2.9 |
| ROE % | 23.4 | 3.8 |
| Net Margin % | 17.8 | 3.9 |
| Rev Growth 5Y % | 12.8 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.38
$5.21 – $5.51
|
3.7 B | 1 |
| FY2029 |
$4.55
$4.41 – $4.67
|
3.5 B | 1 |
| FY2028 |
$4.06
$3.93 – $4.16
|
3.2 B | 1 |
Key Takeaways
Revenue grew 12.75% annually over 5 years — strong growth
ROE of 23.38% indicates high profitability
Net margin of 17.79% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -281.24M
Capital intensive — 36.35% of revenue goes to capex
Growth
Revenue Growth (5Y)
12.75%
Revenue (1Y)12.45%
Earnings (1Y)7.01%
FCF Growth (3Y)N/A
Quality
Return on Equity
23.38%
ROIC25.22%
Net Margin17.79%
Op. Margin27.28%
Safety
Debt / Equity
0.01
Current Ratio1.61
Interest Coverage7.83
Valuation
P/E Ratio
27.87
P/B Ratio6.19
EV/EBITDA17.70
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.45% | Revenue Growth (3Y) | 12.40% |
| Earnings Growth (1Y) | 7.01% | Earnings Growth (3Y) | 15.48% |
| Revenue Growth (5Y) | 12.75% | Earnings Growth (5Y) | 4.08% |
| Profitability | |||
| Revenue (TTM) | 2.34B | Net Income (TTM) | 416.51M |
| ROE | 23.38% | ROA | 8.11% |
| Gross Margin | 68.34% | Operating Margin | 27.28% |
| Net Margin | 17.79% | Free Cash Flow (TTM) | -281.24M |
| ROIC | 25.22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 1.61 |
| Interest Coverage | 7.83 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 27.87 | P/B Ratio | 6.19 |
| P/S Ratio | 4.96 | PEG Ratio | 3.09 |
| EV/EBITDA | 17.70 | Dividend Yield | 0.02% |
| Market Cap | 11.61B | Enterprise Value | 11.31B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2.34B | 2.08B | 1.85B | 1.58B | 1.45B |
| Net Income | 416.51M | 389.21M | 312.34M | 385.97M | 354.98M |
| EPS (Diluted) | 1.99 | 1.86 | 1.49 | 1.85 | 1.70 |
| Gross Profit | 1.60B | 1.48B | 1.29B | 1.15B | 1.04B |
| Operating Income | 638.86M | 558.01M | 437.33M | 490.19M | 469.02M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 5.13B | 4.21B | 4.00B | 2.82B | 2.71B |
| Total Liabilities | 3.26B | 2.52B | 2.45B | 1.43B | 1.44B |
| Shareholders' Equity | 1.88B | 1.69B | 1.55B | 1.38B | 1.28B |
| Total Debt | 22.85M | 99.93M | 1.72B | 992.19M | 1.06B |
| Cash & Equivalents | 322.42M | 221.81M | 284.73M | 244.58M | 188.23M |
| Current Assets | 1.49B | 1.20B | 1.19B | 850.10M | 772.95M |
| Current Liabilities | 929.06M | 1.00B | 923.74M | 626.42M | 578.46M |